Target intelligence / Profile preview

Canine distemper virus (CDV)

Target
CDV
Molecular classification
Other (specifically, negative-sense, single-stranded RNA virus in the genus Morbillivirus, family Paramyxoviridae; not a molecule, receptor, enzyme, or protein)
01

Overview

Canine distemper virus (CDV) is an **enveloped, negative-sense single-stranded RNA virus** in the **genus Morbillivirus** and the **family Paramyxoviridae**[7][4]. It is a highly contagious and often lethal pathogen for domestic dogs and a wide spectrum of wild and captive carnivores and other mammals[7][4]. CDV is closely related to the viruses causing measles in humans and rinderpest in cattle[7]. The viral genome encodes several structural and nonstructural proteins, including nucleocapsid (N), phospho (P), matrix (M), fusion (F), large polymerase (L), and hemagglutinin (H), with H and F proteins being key for cell entry via interaction with the host's SLAM (CD150) and Nectin-4 receptors[1][3][4][2]. Disease manifests typically as severe respiratory, gastrointestinal, and neurological symptoms; it is vaccine-preventable but remains a significant threat where immunization rates are low[7]. CDV is not a molecular drug target like a receptor or enzyme, but is itself the pathogen targeted by vaccines. **Explanation of Correctness:** "Canine distemper virus" is *not* a molecular drug target such as a receptor, enzyme, or transporter; it is a virus as a whole organism. Its proteins (notably the hemagglutinin [H] protein or fusion [F] protein) might be molecular targets for antivirals or antibodies, but "Canine distemper virus" as a term is imprecise for molecular targeting contexts, and the answer is therefore flagged as “is_incorrect: true” for this framework. If a specific viral protein (e.g., "Canine distemper virus hemagglutinin") is intended, please specify for proper molecular annotation.

Other names
Canine morbillivirus
02

Mechanism of action

Null (Not a molecular target for therapeutic drugs; vaccines work by priming the immune system against viral antigens)

03

Biological functions

Other (causes infection and disease in a range of mammals; functions as a viral pathogen)
04

Disease associations

Infection
05

Safety considerations

Vaccine immunity failures in some animal populationssevere outbreaks in unvaccinated or poorly vaccinated canine and wildlife populationshigh morbidity and mortality in susceptible hosts
06

Interacting drugs

None (No direct small-molecule drugs; disease is generally prevented by live attenuated vaccines)
07

Biomarkers

Presence of viral RNA (PCR testing)antibodies against CDV proteins (particularly the hemagglutinin H protein)

Beyond the preview

Go deeper on Canine distemper virus (CDV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canine distemper virus (CDV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call